Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|June 17, 2021
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete LipodystrophyAyako Nagayama, Kenji Ashida, Miki Watanabe, et al.
Pediatric Surgery International|November 13, 2024
Favorable inhibitory effect of clodronate on hepatic steatosis in short bowel syndrome model ratsYudai Tsuruno, Ayaka Nagano, Koshiro Sugita, et al.
Clinical Case Reports|April 27, 2022
Eruptive xanthomas as a marker for metabolic disorders: A specific form of xanthoma that reflects hypertriglyceridemiaSohichiroh Ohtaki, Kenji Ashida, Yuko Matsuo, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing's Syndrome and Autonomous Cortisol SecretionSatoko Oda, Kenji Ashida, Makiko Uchiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2017
Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory painYuri Kato, Miki Hiasa, Reiko Ichikawa, et al.
Frontiers in Endocrinology|November 24, 2025
Sodium-glucose cotransporter 2 inhibitors-but not insulin-enhance renal branched-chain amino acid catabolismMoeko Sakamoto, Nao Hasuzawa, Lixiang Wang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 5, 2026
Vesicular nucleotide transporter (VNUT)-dependent ATP secretion by hepatic stellate cells promotes liver fibrosisMasaharu Kabashima, Nao Hasuzawa, Lixiang Wang, et al.
Endocrine Oncology (Bristol, England)|October 12, 2023
Metyrosine-associated endocrinological changes in pheochromocytoma and paragangliomaYuko Matsuo, Kenji Ashida, Ayako Nagayama, et al.
Diabetology International|April 27, 2026
Analysis of lifestyle factors related to improving blood glucose metabolism by continuous glucose monitoring: a multicenter study in the Chikugo regionHitomi Nakayama, Toshihiko Hashinaga, Kentaro Yamada, et al.
Journal of the Endocrine Society|November 14, 2019
Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case ReportAyako Nagayama, Kenji Ashida, Kanoko Moritaka, et al.
Pageof 5